Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) EPS (Weighted Average and Diluted): 2023-2025

Historic EPS (Weighted Average and Diluted) for Camp4 Therapeutics (CAMP) over the last 2 years, with Sep 2025 value amounting to -$0.55.

  • Camp4 Therapeutics' EPS (Weighted Average and Diluted) rose 97.73% to -$0.55 in Q3 2025 from the same period last year, while for Sep 2025 it was $63.67, marking a year-over-year increase of 159.54%. This contributed to the annual value of -$11.04 for FY2024, which is 91.15% up from last year.
  • As of Q3 2025, Camp4 Therapeutics' EPS (Weighted Average and Diluted) stood at -$0.55, which was up 11.29% from -$0.62 recorded in Q2 2025.
  • Camp4 Therapeutics' EPS (Weighted Average and Diluted)'s 5-year high stood at $65.46 during Q4 2024, with a 5-year trough of -$30.18 in Q4 2023.
  • Over the past 3 years, Camp4 Therapeutics' median EPS (Weighted Average and Diluted) value was -$24.19 (recorded in 2024), while the average stood at -$8.05.
  • Data for Camp4 Therapeutics' EPS (Weighted Average and Diluted) shows a peak YoY spiked of 316.90% (in 2024) over the last 5 years.
  • Over the past 3 years, Camp4 Therapeutics' EPS (Weighted Average and Diluted) (Quarterly) stood at -$30.18 in 2023, then spiked by 316.90% to $65.46 in 2024, then spiked by 97.73% to -$0.55 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.55 for Q3 2025, versus -$0.62 for Q2 2025 and -$0.62 for Q1 2025.